Literature DB >> 22493271

Structural insights into biased G protein-coupled receptor signaling revealed by fluorescence spectroscopy.

Rita Rahmeh1, Marjorie Damian, Martin Cottet, Hélène Orcel, Christiane Mendre, Thierry Durroux, K Shivaji Sharma, Grégory Durand, Bernard Pucci, Eric Trinquet, Jurriaan M Zwier, Xavier Deupi, Patrick Bron, Jean-Louis Banères, Bernard Mouillac, Sébastien Granier.   

Abstract

G protein-coupled receptors (GPCRs) are seven-transmembrane proteins that mediate most cellular responses to hormones and neurotransmitters, representing the largest group of therapeutic targets. Recent studies show that some GPCRs signal through both G protein and arrestin pathways in a ligand-specific manner. Ligands that direct signaling through a specific pathway are known as biased ligands. The arginine-vasopressin type 2 receptor (V2R), a prototypical peptide-activated GPCR, is an ideal model system to investigate the structural basis of biased signaling. Although the native hormone arginine-vasopressin leads to activation of both the stimulatory G protein (Gs) for the adenylyl cyclase and arrestin pathways, synthetic ligands exhibit highly biased signaling through either Gs alone or arrestin alone. We used purified V2R stabilized in neutral amphipols and developed fluorescence-based assays to investigate the structural basis of biased signaling for the V2R. Our studies demonstrate that the Gs-biased agonist stabilizes a conformation that is distinct from that stabilized by the arrestin-biased agonists. This study provides unique insights into the structural mechanisms of GPCR activation by biased ligands that may be relevant to the design of pathway-biased drugs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22493271      PMCID: PMC3340029          DOI: 10.1073/pnas.1201093109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Atomic scale movement of the voltage-sensing region in a potassium channel measured via spectroscopy.

Authors:  A Cha; G E Snyder; P R Selvin; F Bezanilla
Journal:  Nature       Date:  1999-12-16       Impact factor: 49.962

2.  Value of novelty?

Authors:  Philip Ma; Rodney Zemmel
Journal:  Nat Rev Drug Discov       Date:  2002-08       Impact factor: 84.694

Review 3.  Ligand-selective receptor conformations revisited: the promise and the problem.

Authors:  Terry Kenakin
Journal:  Trends Pharmacol Sci       Date:  2003-07       Impact factor: 14.819

4.  Non-ionic amphiphilic homopolymers: synthesis, solution properties, and biochemical validation.

Authors:  K Shivaji Sharma; Grégory Durand; Frank Gabel; Paola Bazzacco; Christel Le Bon; Emmanuelle Billon-Denis; Laurent J Catoire; Jean-Luc Popot; Christine Ebel; Bernard Pucci
Journal:  Langmuir       Date:  2012-02-29       Impact factor: 3.882

5.  Association of beta-arrestin with G protein-coupled receptors during clathrin-mediated endocytosis dictates the profile of receptor resensitization.

Authors:  R H Oakley; S A Laporte; J A Holt; L S Barak; M G Caron
Journal:  J Biol Chem       Date:  1999-11-05       Impact factor: 5.157

6.  Effects of the luteinising hormone-releasing hormone (LH-RH) agonist leuprolide on adenylyl cyclase regulation through G-protein coupled receptors in rat ventral prostate.

Authors:  A Salvador; M P García-Paramio; M Sánchez-Chapado; M J Carmena; J C Prieto
Journal:  Eur J Cancer       Date:  2001-03       Impact factor: 9.162

7.  Sequential binding of agonists to the beta2 adrenoceptor. Kinetic evidence for intermediate conformational states.

Authors:  Gayathri Swaminath; Yang Xiang; Tae Weon Lee; Jacqueline Steenhuis; Charles Parnot; Brian K Kobilka
Journal:  J Biol Chem       Date:  2003-10-14       Impact factor: 5.157

8.  Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors.

Authors:  Mounia Azzi; Pascale G Charest; Stéphane Angers; Guy Rousseau; Trudy Kohout; Michel Bouvier; Graciela Piñeyro
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-17       Impact factor: 11.205

9.  Structure and conformational changes in the C-terminal domain of the beta2-adrenoceptor: insights from fluorescence resonance energy transfer studies.

Authors:  Sébastien Granier; Samuel Kim; Aaron M Shafer; Venkata R P Ratnala; Juan José Fung; Richard N Zare; Brian Kobilka
Journal:  J Biol Chem       Date:  2007-03-08       Impact factor: 5.157

10.  Crystal structure of the β2 adrenergic receptor-Gs protein complex.

Authors:  Søren G F Rasmussen; Brian T DeVree; Yaozhong Zou; Andrew C Kruse; Ka Young Chung; Tong Sun Kobilka; Foon Sun Thian; Pil Seok Chae; Els Pardon; Diane Calinski; Jesper M Mathiesen; Syed T A Shah; Joseph A Lyons; Martin Caffrey; Samuel H Gellman; Jan Steyaert; Georgios Skiniotis; William I Weis; Roger K Sunahara; Brian K Kobilka
Journal:  Nature       Date:  2011-07-19       Impact factor: 49.962

View more
  73 in total

Review 1.  Optical probes based on G protein-coupled receptors - added work or added value?

Authors:  A D Stumpf; C Hoffmann
Journal:  Br J Pharmacol       Date:  2015-12-19       Impact factor: 8.739

2.  A G Protein-biased Designer G Protein-coupled Receptor Useful for Studying the Physiological Relevance of Gq/11-dependent Signaling Pathways.

Authors:  Jianxin Hu; Matthew Stern; Luis E Gimenez; Lizzy Wanka; Lu Zhu; Mario Rossi; Jaroslawna Meister; Asuka Inoue; Annette G Beck-Sickinger; Vsevolod V Gurevich; Jürgen Wess
Journal:  J Biol Chem       Date:  2016-02-05       Impact factor: 5.157

3.  Heterodimerization with Its splice variant blocks the ghrelin receptor 1a in a non-signaling conformation: a study with a purified heterodimer assembled into lipid discs.

Authors:  Sophie Mary; Jean-Alain Fehrentz; Marjorie Damian; Gérald Gaibelet; Hélène Orcel; Pascal Verdié; Bernard Mouillac; Jean Martinez; Jacky Marie; Jean-Louis Banères
Journal:  J Biol Chem       Date:  2013-07-09       Impact factor: 5.157

4.  Structural dynamics and energetics underlying allosteric inactivation of the cannabinoid receptor CB1.

Authors:  Jonathan F Fay; David L Farrens
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-22       Impact factor: 11.205

Review 5.  Advances in receptor conformation research: the quest for functionally selective conformations focusing on the β2-adrenoceptor.

Authors:  Anthony Yiu-Ho Woo; Ying Song; Weizhong Zhu; Rui-Ping Xiao
Journal:  Br J Pharmacol       Date:  2015-02-27       Impact factor: 8.739

Review 6.  Multi-functionality of proteins involved in GPCR and G protein signaling: making sense of structure-function continuum with intrinsic disorder-based proteoforms.

Authors:  Alexander V Fonin; April L Darling; Irina M Kuznetsova; Konstantin K Turoverov; Vladimir N Uversky
Journal:  Cell Mol Life Sci       Date:  2019-08-19       Impact factor: 9.261

7.  Gating function of isoleucine-116 in TM-3 (position III:16/3.40) for the activity state of the CC-chemokine receptor 5 (CCR5).

Authors:  A Steen; A H Sparre-Ulrich; S Thiele; D Guo; T M Frimurer; M M Rosenkilde
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

8.  Inhibition of follicle-stimulating hormone-induced preovulatory follicles in rats treated with a nonsteroidal negative allosteric modulator of follicle-stimulating hormone receptor.

Authors:  James A Dias; Brice Campo; Barbara A Weaver; Julie Watts; Kerri Kluetzman; Richard M Thomas; Béatrice Bonnet; Vincent Mutel; Sonia M Poli
Journal:  Biol Reprod       Date:  2014-01-30       Impact factor: 4.285

Review 9.  G-Protein-Coupled Receptors in Heart Disease.

Authors:  Jialu Wang; Clarice Gareri; Howard A Rockman
Journal:  Circ Res       Date:  2018-08-31       Impact factor: 17.367

Review 10.  Amphipols in G protein-coupled receptor pharmacology: what are they good for?

Authors:  Sophie Mary; Marjorie Damian; Rita Rahmeh; Bernard Mouillac; Jacky Marie; Sébastien Granier; Jean-Louis Banères
Journal:  J Membr Biol       Date:  2014-05-07       Impact factor: 1.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.